These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36510939)

  • 1. Tuberculosis treatment-related lichenoid drug eruptions.
    Katran ZY; Bulut I; Babalık A
    Int J Mycobacteriol; 2022; 11(4):469-471. PubMed ID: 36510939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lichenoid drug eruption with antituberculosis drugs associated with an anonychia].
    BayBay H; Saàdani C; Elloudi S; Douhi Z; Rimani M; Achour S; Mernissi FZ
    Ann Dermatol Venereol; 2020; 147(6-7):456-460. PubMed ID: 32229034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug.
    Katran ZY; Bulut I; Babalik A; Keren M
    Int J Mycobacteriol; 2022; 11(3):309-317. PubMed ID: 36260451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
    Sharma PK; Gautam RK; Bhardwaj M; Kar HK
    J Dermatol; 2001 Dec; 28(12):737-41. PubMed ID: 11804071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of isoniazid-induced lichenoid drug eruption with acitretin.
    Chen C; Nguyen GH; Zeng YP; Wang BX
    Eur J Dermatol; 2018 Feb; 28(1):82-83. PubMed ID: 29171404
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed lichenoid and psoriasiform drug eruption induced by rifampicin.
    Feng X; Ye X; Xu J; Li C
    Australas J Dermatol; 2020 May; 61(2):e231-e233. PubMed ID: 31840241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
    Özkaya E
    Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two patients with isoniazid-induced photosensitive lichenoid eruptions confirmed by photopatch test.
    Lee AY; Jung SY
    Photodermatol Photoimmunol Photomed; 1998 Apr; 14(2):77-8. PubMed ID: 9638730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lichenoid drug reaction to isoniazid presenting as exfoliative dermatitis in a patient with acquired immunodeficiency syndrome.
    Thakur BK; Verma S; Mishra J
    Int J STD AIDS; 2015 Jun; 26(7):512-5. PubMed ID: 25013221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
    Parthasarathy R; Sarma GR; Janardhanam B; Ramachandran P; Santha T; Sivasubramanian S; Somasundaram PR; Tripathy SP
    Tubercle; 1986 Jun; 67(2):99-108. PubMed ID: 3775870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
    Costin M; Tesloianu A; Mihăescu T; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethambutol Induced Lichenoid Drug Eruption: A Case Report.
    Yuyaem T; Sudchada P; Srisuttiyakorn C; Juntawong J; Khanngern N; Watcharapokin N; Chansangiam P
    Curr Drug Saf; 2021; 16(3):296-298. PubMed ID: 33334297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
    Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Kajiki A
    J Infect Chemother; 2011 Aug; 17(4):530-3. PubMed ID: 21188445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
    Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
    Wada M
    Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance and complications of antituberculosis chemotherapy].
    Duroux P
    Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-tuberculosis chemotherapy and management of adverse reactions].
    Kuwabara K
    Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.